ORINY - Bayers to seek label expansion for prostate cancer drug after late-stage trial win
2024-07-17 14:56:50 ET
More on Bayer
- Bayer: Small Signs Of Improvement Are Not Enough
- Bayer AG (BAYZF) Q1 2024 Earnings Call Transcript
- Bayer Aktiengesellschaft 2024 Q1 - Results - Earnings Call Presentation
- Bayer's $2.25B Roundup verdict cut to $400M by Pennsylvania judge
- Burning Rock Biotech joins hands with Bayer to expand precision cancer therapies portfolio